Zoekresultaten - 105 results

Molecular epidemiology of airway colonisation by Aspergillus fumigatus in cystic fibrosis patients36698

same sample, unlike the chronically colonised patients, who harboured a limited number of genotypes. In the latter, the occurrence of a dominant genotype, usually the overall genotype 2, tended to ...

The perinatal presence of antigen (p-azophenylarsonate) or anti-mu antibodies lead to the loss of the recurrent idiotype (CRIA) in A/J mice.

Mice, Inbred A p-Azobenzenearsonate Stem Cells Abstract: The immune response of A/J mice against p-azophenylarsonate (Ars)-keyhole limpet hemocyanin (KLH) is characterized by the dominance, late in ...

Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively.

Publication Type: Peer reviewed scientific article Authors: C Adlhoch; R Snacken; A Melidou; S Ionescu; P Penttinen; et al. Source: (0) Health Topics:  Health and disease monitoring Surveillance de la santé et des maladies Ziekten en gezondheid in kaart b ...

Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively.

especially in people aged 60 years and older. Influenza A(H3N2) virus dominated in 2016/17 and B/Yamagata in 2017/18. The latter season was prolonged with positivity rates above 50% among sentinel detections ...

Dissecting the molecular evolution of fluoroquinolone-resistant Shigella sonnei.

Shigella sonnei Abstract: Shigella sonnei increasingly dominates the international epidemiological landscape of shigellosis. Treatment options for S. sonnei are dwindling due to resistance to several key ...

Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.

dominated by influenza A (H1N1)pdm09 and (H3N2) viruses, with very few influenza B viruses detected. METHODS: Countries in the European Region reported virus characterization data to The European Surveillance ...

Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening.

HPV screening every 5 year is a dominant option, compared to current practice of cytology screening every 3 years. Health Topics:  Quality of healthcare Cancer Qualité des soins de santé Kwaliteit van ...

QR code

QR code for this page URL